Tribuvia (seniprutug) / Biocad - LARVOL DELTA

Clinical Efficacy of Seniprutug (BCD-180), anti-TRBV9 therapy for radiographic Axial Spondyloarthritis (APLAR 2024) - No abstract available

Clinical • Ankylosing Spondylitis • Immunology • Seronegative Spondyloarthropathies • Spondylarthritis

Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA) (clinicaltrials.gov) - P3 | N=421 | Active, not recruiting | Sponsor: Biocad | Recruiting ➔ Active, not recruiting

Enrollment closed • Ankylosing Spondylitis • Immunology • Seronegative Spondyloarthropathies • Spondylarthritis

Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA) (clinicaltrials.gov) - P3 | N=421 | Recruiting | Sponsor: Biocad

New P3 trial • Ankylosing Spondylitis • Immunology • Seronegative Spondyloarthropathies • Spondylarthritis

Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=39 | Completed | Sponsor: Biocad | Active, not recruiting ➔ Completed

Trial completion

Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=39 | Active, not recruiting | Sponsor: Biocad | Recruiting ➔ Active, not recruiting | Trial completion date: Sep 2022 ➔ Sep 2023 | Trial primary completion date: Sep 2022 ➔ Sep 2023

Enrollment closed • Trial completion date • Trial primary completion date

ELEFTA: Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (clinicaltrials.gov) - P2 | N=250 | Active, not recruiting | Sponsor: Biocad | Recruiting ➔ Active, not recruiting

Enrollment closed • Ankylosing Spondylitis • Immunology • Seronegative Spondyloarthropathies • Spondylarthritis • CRP

ELEFTA: Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (clinicaltrials.gov) - P2 | N=250 | Recruiting | Sponsor: Biocad

New P2 trial • Ankylosing Spondylitis • Immunology • Seronegative Spondyloarthropathies • Spondylarthritis • CRP

Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=39 | Recruiting | Sponsor: Biocad

New P1 trial